Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic or orthopedic industry newsletters.

Ophthalmic Orthopedic

Recently Added ophthalmic

1/15/2021
BreakingClinical TrialCornealOphthalmic
First Implanted Patient Regains Sight with CorNeat Vision’s Artificial Cornea
First Implanted Patient Regains Sight with CorNeat Vision’s Artificial Cornea

Israel’s CorNeat Vision announced Jan. 11 that its KPro artificial cornea implant restored sight in the first treated patient, a 78-year-old man. Professor Irit Bahar, MD, at Rabin Medical Center i...

1/15/2021
BreakingCataractIOLOphthalmicSurgical
Alcon Launches Vivity Non-diffractive EDOF PC-IOL
Alcon Launches Vivity Non-diffractive EDOF PC-IOL

Alcon reported Jan. 7 the full US launch of the AcrySof IQ Vivity IOL, a non-diffractive extended depth of focus intraocular lens designed for presbyopic patients. The Switzerland-registered, Texas...

1/15/2021
BreakingOphthalmicRegulation
US Regulatory Roundup: Ophthalmologists Now to See Increase in 2021, Plus Other Updates
US Regulatory Roundup: Ophthalmologists Now to See Increase in 2021, Plus Other Updates

A US spending package signed into law on Dec. 27 erased the impact of Medicare’s negative physician fee adjustments for eye care providers in 2021. Ophthalmologists were prepared to see an average ...

1/15/2021
BreakingCataractDry EyeOphthalmicSurgical
IACTA, Pharmaleads Partner on Ocular Pain Candidates with Potential Endothelial Protective Properties
IACTA, Pharmaleads Partner on Ocular Pain Candidates with Potential Endothelial Protective Properties

IACTA Pharmaceuticals announced Jan. 7 that it had acquired global rights to Pharmaleads’ dual enkephalinase inhibitors (DENKIs), a novel class of non-opioid compounds for the treatment of acute an...

1/15/2021
BreakingDry EyeOphthalmicPharma
Kala Launches Eysuvis for Short-Term Treatment of Dry Eye
Kala Launches Eysuvis for Short-Term Treatment of Dry Eye

Kala Pharmaceuticals announced Jan. 7 that it had launched Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs and symptoms of dr...

1/15/2021
BreakingGlaucomaLaserOphthalmicRegulationRetina
Norlase Gains CE Marking for LION Green Laser System
Norlase Gains CE Marking for LION Green Laser System

Norlase announced Jan. 5 that it had been granted CE marking in Europe for its LION, a green laser photocoagulator fully integrated into the headset of a Keeler indirect ophthalmoscope. The LION wa...

1/15/2021
BreakingGlaucomaOphthalmicPharmaRegulation
Aerie Gains EU Marketing Authorization for Roclanda
Aerie Gains EU Marketing Authorization for Roclanda

Aerie Pharmaceuticals announced Jan. 11 that the European Commission had granted marketing authorization for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction...

1/15/2021
BreakingDry EyeOphthalmicPharma
SIFI Launches Synfo Dry Eye Treatment
SIFI Launches Synfo Dry Eye Treatment

Italian company SIFI announced Jan. 7 that it had launched Synfo, a treatment for dry eye disease. The new hypotonic formulation is a blend of two polymers, sodium hyaluronate and xanthan gum, and ...

1/8/2021
BreakingDealsDeviceLow VisionOphthalmic
Pixium, Second Sight to Combine Operations, with New Company Trading on Nasdaq
Pixium, Second Sight to Combine Operations, with New Company Trading on Nasdaq

French company Pixium Vision and Second Sight Medical Products, of California, announced Jan. 6 that the two would combine operations. Pixium will contribute to Second Sight all of its assets and l...

1/8/2021
BreakingCOVID-19MeetingOphthalmic
ASRS Moves 2021 Annual Meeting to October in Texas; Glaucoma 360 Goes Virtual
ASRS Moves 2021 Annual Meeting to October in Texas; Glaucoma 360 Goes Virtual

The American Society of Retina Specialists announced on its website that it plans to hold its 2021 annual meeting Oct. 8-12 at the JW Marriott San Antonio Hill Country Resort and Spa in Texas. The ...

1/8/2021
BreakingDealsGene TherapyOphthalmicRetina
ViGeneron, Biogen Team Up on Ophthalmic Gene Therapies
ViGeneron, Biogen Team Up on Ophthalmic Gene Therapies

German gene therapy company ViGeneron announced Jan. 5 that it had reached a global collaboration and licensing agreement with Biogen to develop and commercialize gene therapy products to treat inh...

1/8/2021
BreakingOphthalmicPharmaRegulation
Eyenovia Submits NDA to US FDA for Fixed Combination Mydriatic Agent
Eyenovia Submits NDA to US FDA for Fixed Combination Mydriatic Agent

Eyenovia, of New York, announced Dec. 29 that it had submitted a new drug application (NDA) to the US FDA for MydCombi, a fixed combination mydriatic (pupil dilation) agent. MydCombi (phenylephrine...

Past News Stories

1/8/2021
BreakingClinical TrialOphthalmicPharma
Ocumension Initiates Phase III Trial of Zerviate in China
Ocumension Initiates Phase III Trial of Zerviate in China

Ocumension Therapeutics, of Hong Kong, announced Dec. 29 that it had initiated a Phase III trial in China of Zerviate (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching asso...

1/8/2021
BreakingDiagnosticOphthalmic
VisionQuest Biomedical Gains US FDA 510(k) Clearance for Retinal Image Software
VisionQuest Biomedical Gains US FDA 510(k) Clearance for Retinal Image Software

VisionQuest Biomedical announced Dec. 30 that the company had received 510(k) clearance from the US FDA to market its Image Quality Analyzer (IQA) software. The software detects the most common cau...

1/8/2021
BreakingOphthalmicRetina
Samsara Vision, Formerly VisionCare, Appoints Three New Board Members
Samsara Vision, Formerly VisionCare, Appoints Three New Board Members

Samsara Vision, formerly VisionCare, maker of the Implantable Miniature Telescope for patients with late-stage age-related macular degeneration (AMD), announced Jan. 4 that it had appointed three n...

1/8/2021
BreakingFundingOphthalmicPharmaRetina
NGM Bio Prices Upsized $125 Million Public Offering of Common Stock
NGM Bio Prices Upsized $125 Million Public Offering of Common Stock

NGM Biopharmaceuticals, of South San Francisco, California, announced Jan. 5 that it had priced an underwritten public offering of 4,629,630 shares of common stock at $27 per share. The company exp...

1/8/2021
BreakingFundingOphthalmic
Ocular Therapeutix Reports Gross Proceeds of $92.1 Million in Public Offering
Ocular Therapeutix Reports Gross Proceeds of $92.1 Million in Public Offering

Ocular Therapeutix announced Dec. 28 that underwriters of its latest public offering had exercised their full option, resulting in gross proceeds of approximately $92.1 million. Jefferies LLC and P...

1/8/2021
BreakingCornealDry EyeFundingOphthalmic
EyeGate Raises $8 Million in Private Placement
EyeGate Raises $8 Million in Private Placement

EyeGate Pharmaceuticals, of Waltham, Massachusetts, announced Jan. 6 that it had entered into a securities purchase agreement with an affiliate of Armistice Capital for a private placement, with ag...

12/31/2020
AcquisitionsBreakingOphthalmicPharma
EyeGate Acquires Austrian Company Panoptes for $4 Million Up Front
EyeGate Acquires Austrian Company Panoptes for $4 Million Up Front

EyeGate Pharmaceuticals, of Waltham, Massachusetts, announced Dec. 21 that it had acquired Austrian company Panoptes Pharma, a privately held biotech developing a proprietary small molecule for the...

1/5/2021
OphthalmicPress Release
Refractive Surgery to Grow 9.6 Percent a Year Through 2025, Despite COVID-19
Refractive Surgery to Grow 9.6 Percent a Year Through 2025, Despite COVID-19

Expanding use of products to treat refractive error will increase the role of devices and surgical procedures in the refractive landscape. Globally, over 2.3 billion people require vision correctio...

12/31/2020
BreakingCataractIOLOphthalmicSurgical
SIFI Launches Well Fusion System, Blending Two EDOF IOLs
SIFI Launches Well Fusion System, Blending Two EDOF IOLs

Italian company SIFI announced Dec. 21 the launch of its Well Fusion system, blending two extended depth of focus (EDOF) IOLs—the Mini Well and new Mini Well Proxa—in a system designed to address p...

12/31/2020
BreakingCataractOphthalmicSurgical
VSY Launches Protectalon DUO Kit of OVDs for Cataract Surgery
VSY Launches Protectalon DUO Kit of OVDs for Cataract Surgery

VSY Biotechnology, of Germany, announced Dec. 17 the launch of its Protectalon DUO kit, made up of one unit of cohesive and one unit of dispersive ophthalmic viscoelastic devices (OVDs). The kit pr...

12/31/2020
BreakingDiagnosticFundingOphthalmic
Heru Announces Ophthalmic Diagnostic Software for VR Headsets, $2.7M Financing
Heru Announces Ophthalmic Diagnostic Software for VR Headsets, $2.7M Financing

Miami-based Heru, a spinout from Bascom Palmer Eye Institute, announced Dec. 21 that it is developing AI-driven ophthalmic diagnostic software, with visual field exams as the first targeted applica...

12/31/2020
BreakingDealsGene TherapyOphthalmicRetina
Gyroscope, U. of Pennsylvania Join Forces for Ocular Gene Therapies
Gyroscope, U. of Pennsylvania Join Forces for Ocular Gene Therapies

Gyroscope Therapeutics, of London, announced Dec. 18 that the company had entered a sponsored research agreement with the University of Pennsylvania and the Penn Center for Advanced Retinal and Ocu...

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2021 Market Scope, LLC. All Rights reserved.